Director Deals - (SUS)

Anthony Coombs, Director, sold post-exercise 4,375 shares in the company on the 16th April 2021 at a price of £23.50. The Director now holds 1,340,967...

Tue, 11/05/2021 - 15:03


Director Deals - (SUS)

Anthony Coombs, Director, sold post-exercise 625 shares in the company on the 16th April 2021 at a price of £24.00. The Director now holds 1,340,342...

Tue, 11/05/2021 - 15:03


Director Deals - (SUS)

Christopher Redford, Executive Director, has transferred out 1,500 shares in the company on the 16th April 2021 at a price of £0.00. The Director now...

Tue, 11/05/2021 - 15:03


Director Deals - (SUS)

Anthony Coombs, Director, exercised 5,000 shares in the company on the 16th April 2021 at a price of £0.13. The Director now holds 1,345,342 shares....

Tue, 11/05/2021 - 15:03


FTSE slumps 2% as inflation fears mount, tech stocks sell-off

FTSE slumps 2% as inflation fears mount, tech stocks sell-off

The FTSE 100 had slumped 2.2% to 6,969.14 by midday after an overnight rout in...

Tue, 11/05/2021 - 12:15


Inflation worries sink FTSE and supply deals help to lift Morrisons

“The market just can’t shake the inflation fears which are clouding the recovery from Covid,” says AJ Bell Investment Director Russ Mould.

“Some days...

Tue, 11/05/2021 - 10:47


Joules upgrades outlook on growth ahead of further easing Covid-19 restrictions

Lifestyle brand Joules upgraded its outlook on revenue and profit following strong digital sales and the confirmation of further easing of lockdown restrictions in England....

Tue, 11/05/2021 - 09:55


ULS Technology upgrades guidance as sales recover

Conveyancing services group ULS Technology upgraded its guidance, forecasting a shallower-than-feared underlying loss thanks to a recovery in sales.

Underlying pre-tax losses for the year...

Tue, 11/05/2021 - 09:51


Kromek sees annual performance in line with market expectations as momentum continues

Detection technology supplier Kromek said it was on track to meet market expectations as momentum seen in the final months of the first half of...

Tue, 11/05/2021 - 09:51


Angle's parsortix system identifies therapeutic targets in breast cancer study

Liquid biopsy company, Angle said cancer research institute, Fondazione IRCCS Istituto Nazionale dei Tumori, in Italy, used the company's parsortix system to isolate circulating tumour...

Tue, 11/05/2021 - 09:44


Pages